Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas

Technology
E-302-2000
Patent ID
E-302-2000-2-US-02
Country
US
Application Type
ORD
Patent Status
Abandoned
Patent Number
 
Publication Number
US-2002-0054869-A1
Application Number
09/942,940
IC
NCI
Date Filed
Date Issued
 
Patent PDF